PRKN and Parkinson disease: In conclusion, we identify here multiple lipid alterations in the absence of parkin that could help us understand the molecular basis of the disease and find new therapeutic targets to stimulate the autophagic process and revert the aggregation of toxic proteins in Parkinson’s disease pathology.